Clonal evolution of chemotherapy-resistant urothelial carcinoma. - Wikidata - awgldk - TriplyDB

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

http://www.wikidata.org/entity/Q41315076

about

A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy.Current markers and their value in the era of immuno-oncology.Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance.Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes.Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockade.Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.Blood- and tissue-based tumor genomics: a battle royale or match made in heaven?Rapid autopsy of a patient with recurrent anaplastic ependymoma.Copy number profiles of paired primary and metastatic colorectal cancers.Tumour heterogeneity and resistance to cancer therapies.From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity.Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.Short- and long-term evolution in our arms race with cancer: Why the war on cancer is winnable.Q58714444

P2860

Q37739072-C827AB18-7ADF-4596-B4BD-EB7B19505CE1 Q39459198-CC619113-A9C8-4703-B819-94CF319DB86F Q41198823-725AC9C8-AF73-44D3-9862-CBC9B58078E8 Q47111129-D2F23CDC-127B-4B22-853E-C7BC300132FE Q47406496-EF943B57-C6EB-462A-9EC1-1405960B8913 Q47555165-76A83F9E-8303-4E90-AA66-043161EE5F13 Q47558605-FB67962E-E4B2-4284-B306-CAFA274C2226 Q47568875-4040E982-8E95-483E-80F3-0CF77FA09B03 Q47721195-D3EEBFC2-842D-41CB-B4B3-D68BF3F209D0 Q47926486-48121F2A-8EFE-4E7E-8414-709136A67214 Q48028604-4327F5BA-09A2-40D6-9ECF-895C45ECB2BB Q49574999-D60D177E-8D7E-4C46-BE50-2EE11B27D9F6 Q49728493-AE104B9D-7947-4D8E-8EBB-DDD51CFFBD1A Q49842940-1592E6AE-44BB-4309-AB9C-9A1FAF11E380 Q49887099-240B6357-7AF1-451B-8C58-C5FCAB27B704 Q50105696-B6FA47BF-E680-4A7F-862F-6B1A9B3DEDB1 Q50112440-DBAD4444-6830-48DC-9DF7-3B63A7781A43 Q50351390-5A8705A6-2E2B-4B47-9BCA-21CE6CC1C738 Q52602391-6A1099A3-5443-4696-894C-F433C8FED1EF Q55465529-955D74C6-1A8B-4463-8AF9-DFF1F680A7D1 Q58714444-04C99345-7E72-4CA9-8739-C7730982FF70

P2860

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

http://www.wikidata.org/entity/Q41315076

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

@en

type

label

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

@en

prefLabel

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

@en

P1433

Q41315076-035B0102-AE85-48D1-B681-5B32C28EBA2E

P1476

Q41315076-E0ED7B34-C000-418C-AA0D-B3B580A49100

P2093

Q41315076-2FCFC2B5-4CEF-46D3-8B9F-E6F2AE511756

Q41315076-3508F854-F23F-4C51-B577-4AE7D75F64A4

Q41315076-41AB8862-833B-43D0-919B-26AED08F6087

Q41315076-53B3248E-46F5-4F48-A199-0AAE9E34535A

Q41315076-5D637BC9-5729-4515-9A9D-1391F50DB819

Q41315076-96195977-CDD1-4B6C-BBFD-57DCF0BA6E13

Q41315076-973A10E5-9401-4796-86E8-67D752BC0AB5

Q41315076-AA5F8570-77DF-4105-9F73-3A115D642C99

Q41315076-BD6DC539-C592-4679-8583-3B26827A4EC9

Q41315076-C8D01A82-DF4E-47A7-892B-47335C3DCB46

P2860

Q41315076-00A5C4CC-75D0-45E2-9D28-65FEB244E1AE

Q41315076-0382BD2C-E12C-434F-A785-686E7654CC22

Q41315076-05481EE6-B3C4-42F6-901B-EC6CDB7E497E

Q41315076-05E89819-E4B2-4C96-A603-2636B65E4BBB

Q41315076-0F7935A5-98B8-43F6-995D-3B700FC31FC0

Q41315076-1111AA66-AB42-4A08-AA1E-82E676FEA602

Q41315076-159C45BD-8FC4-44A4-A270-83342D19B882

Q41315076-15C0AB4E-77BD-45D8-8526-4AB64A3B6CDE

Q41315076-1A7786E9-6CA7-4035-987E-DE1D55DE1191

Q41315076-1ED1C4B6-9304-4D8B-ACDE-09B1A557B74F

P2888

Q41315076-1069F0A1-BD3A-4E2A-8153-AD154DAAC730

P304

Q41315076-AEFC522A-0046-4B8F-934D-58EED017E4C3

P31

Q41315076-2DCA8798-EEBF-4DA1-B70F-A70BAA60790E

P356

Q41315076-794F7BC0-19A4-4F9C-A739-CA317C0399C7

P407

Q41315076-C3C87CA8-71EA-4A76-BB40-FABB645518A2

P433

Q41315076-3FAF0973-B9E1-4C49-B01E-848E6BFD9784

P478

Q41315076-DA7568DA-B762-42A3-959F-9F040EED46E7

P50

Q41315076-0D8B43F4-ADA8-4A66-AAC5-9122112A9FED

Q41315076-5077086A-3F26-4641-BF16-90EEF091E345

Q41315076-D00CB027-43AF-4704-9CF0-EA2738579C14

P577

Q41315076-D7C447FF-3E08-406B-A50D-62475F9466FD

P6179

Q41315076-671C6CA9-DBEA-4498-BE3A-A4DDB3EF35EA

P698

Q41315076-B0E44FD3-023E-4A94-914E-3D025750708C

P921

Q41315076-6F99A03C-47FC-45D0-9F1D-C29593364366

P932

Q41315076-69F2B82E-061B-4DC1-A6BF-47010DFC5BA3

P356

P1433

Nature Genetics

P1476

Clonal evolution of chemotherapy-resistant urothelial carcinoma

@en

P2093

Ana M Molina

http://www.w3.org/2001/XMLSchema#string

Andrea Sboner

http://www.w3.org/2001/XMLSchema#string

Brian Robinson

http://www.w3.org/2001/XMLSchema#string

Cora Sternberg

http://www.w3.org/2001/XMLSchema#string

David M Nanus

http://www.w3.org/2001/XMLSchema#string

Davide Prandi

http://www.w3.org/2001/XMLSchema#string

Himisha Beltran

http://www.w3.org/2001/XMLSchema#string

Jonathan Rosenberg

http://www.w3.org/2001/XMLSchema#string

Juan Miguel Mosquera

http://www.w3.org/2001/XMLSchema#string

Olivier Elemento

http://www.w3.org/2001/XMLSchema#string

P2860

The Sequence Ontology: a tool for the unification of genome annotations

Mutational processes molding the genomes of 21 breast cancers

A census of human cancer genes

Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine

The RGD integrin binding site in human L1-CAM is important for nuclear signaling.

Hypermutation in human cancer genomes: footprints and mechanisms

Signalling via integrins: implications for cell survival and anticancer strategies

APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication

Retroviral restriction by APOBEC proteins

Comprehensive molecular characterization of urothelial bladder carcinoma

P2888

P304

1490-1499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.3692

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Demichelis

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047576401

http://www.w3.org/2001/XMLSchema#string

P698

27749842

http://www.w3.org/2001/XMLSchema#string

P921

P932

5549141

http://www.w3.org/2001/XMLSchema#string